In this regard it is worth mentioning that anti-TGF-β antibodies might suppress the transition from epithelial/differentiated tumor cells to mesenchymal/invasive tumor cells, thereby preventing the metastatic dissemination rather than killing the tumor. The gene discussed is TGFB1; the disease is neoplasm.